DGGE method for the mutational analysis of the coding and proximal promoter regions of the alzheimer's disease presenilin-1 gene: Two novel mutations

Human Mutation

Volumn 14, Issue 5, 1999, Pages 433-439

  Aldudo, J ^a   Bullido, M J ^a   Valdivieso, Fernando ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Alzheimer's disease; Denaturing gradient gel electrophoresis; DGGE; Mutation screen; Presenilin 1; Promoter; PSEN1; Transcription regulation

Indexed keywords

PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; DENATURING GRADIENT GEL ELECTROPHORESIS; EXON; GENETIC VARIABILITY; HUMAN; NERVE CELL; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; POINT MUTATION; PRESENILIN-1; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 0032706357     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(199911)14:5<433::AID-HUMU10>3.0.CO;2-K     Document Type: Article

References (35)

1. Aldudo J, Bullido MJ, Arbizu T, Oliva R, Valdivieso F. 1998a. Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease. Neurosci Lett 240:174-176.
2. Aldudo J, Bullido MJ, Frank A, Valdivieso F. 1998b. Missense mutation E318G of the presenilin-1 gene appears to be a nonpathogenic polymorphism. Ann Neurol 44:985-986.
3. Alzheimer's Disease Collaborative Group. 1995. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 11:219-222.
4. Andrews NC, Faller DV. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
5. Artiga MJ, Bullido MJ, Frank A, Sastre I, Recuero M, Garcia MA, Lendon CL, Han SW, Morris JC, Vazquez J, Goate A, Valdivieso F. 1998a. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum Mol Genet 12:1887-1892.
6. Artiga MJ, Bullido MJ, Sastre I, Recuero M, Garcia MA, Aldudo J, Vázquez J, Valdivieso F. 1998b. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 421:105-108.
7. Bouras C, Giannakopoulos P, Schioi J, Tezapsidis J, Robakis NK. 1996. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1185-1186.
8. Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, Lendon C, Han SW, Morris JC, Frank A, Vázquez J, Goate A, Valdivieso F. 1998. A polymorphism in the transcriptional regulatory region of apolipoprotein E associated with risk for dementia of the Alzheimer type. Nat Genet 18:69-71.
9. Cruts M, Van Broeckhoven C. 1998. Presenilin mutations in Alzheimer's disease. Hum Mutat 11:183-190.
10. Cruts M, Van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Van Broeckhoven C. 1998. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenilin Alzheimer disease. Hum Mol Genet 7:43-51.
11. Dermaut B, Cruts M, Slooter AJ, Van Gestel S, De Jonghe C, Vanderstichele H, Vanmechelen E, Breteler MM, Hofman A, van Duijn CM, Van Broeckhoven C. 1999. The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease. Am J Hum Genet 64:290-292.
12. Dumanchin C, Brice A, Campion D, Hannequin D, Martin C, Moreau V, Agid Y, Martinez M, Clerget-Darpoux F, Frebourg T. 1998. De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. J Med Genet 35:672-673.
13. García MA, Vázquez J, Giménez C, Valdivieso F, Zafra F. 1996. Transcriptional factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J Neurosci 16:7550-7556.
14. Giannakopoulos P, Bouras C, Kovari E, Schioi J, Tezapsidis N, Hof PR, Robakis NK. 1997. Presenilin-1 immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am J Pathol 150:429-436.
15. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-709.
16. Kwok JB, Taddei K, Hallupp M, Fisher C, Brooks WS, Broe GA, Hardy J, Fulham MJ, Nicholson GA, Stell R, St George Hyslop PH, Fraser PE, Kakulas B, Clarnett R, Relkin N, Gandy SE, Schofield PR, Martins RN. 1997. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 8:1537-1542.
17. Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC. 1998. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's dementia. Hum Mol Gen 7:533-540.
18. Lerman LS, Silverstein K. 1987. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 155:482-501.
19. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y, Guenette SY, Galas D, Wijsman EM, Bird TD, Schelenberg GD, Tanzi RE. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
20. Mattila KM, Forsell C, Pirttila T, Rinne JO, Lehtimaki T, Roytta M, Lilius L, Eerola A, St George-Hyslop PH, Frey H, Lannfelt L. 1998. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease. Ann Neurol 44:965-967.
21. Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT 1996. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the e4 allele. Neurology 47:196-201.
22. Myers RM, Maniatis T, Lerman LS. 1987. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155:501-527.
23. Myers RM, Sheffield VC, Cox DR. 1988. Detection of single base changes in DNA; ribonuclease cleavage and denaturing gradient gel electrophoresis. In: Davies KE, editor. Genome analysis - a practical approach. Oxford: IRL Press. p 94-139.
24. Poorkaj P, Sharma V, Anderson L, Nemens E, Alonso ME, Orr H, White J, Heston L, Bird TD, Schellenberg GD. 1998. Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene. Hum Mutat 11:216-221.
25. Ramirez-Dueñas MG, Rogaeva EA, Leal CA, Lin C, Ramirez-Casillas GA, Hernandez-Romo JA, St George-Hyslop PH, Cantu JM. 1998. A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family with early onset Alzheimer disease. Ann Genet 41:149-153.
26. Reznik-Wolf H, Treves TA, Shabtai H, Aharon-Peretz J, Chapman J, Davidson M, Barkai G, Hyslop PH, Goldman B, Korczyn AD, Friedman E. 1998. Germline mutational analysis of presenilin 1 and APP genes in Jewish-Israeli individuals with familial or early-onset Alzheimer disease using denaturing gradient gel electrophoresis (DGGE). Eur J Hum Genet 6:176-180.
27. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St George-Hyslop PH. 1995. Familial Alzheimer's disease in kindreds with missense in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778.
28. Rogaev EI, Sherrington R, Wu C, Levesque G, Liang Y, Rogaeva EA, Ikeda M, Holman K, Lin C, Lukiw WJ, de Jong PJ, Fraser PE, Rommens JM, St George-Hyslop P. 1997. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 40:415-424.
29. Sandbrink R, Zhang D, Schaeffer S, Masters CL, Bauer J, Forstl H, Beyreuther K. 1996. Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients. Ann Neurol 40:265-266.
30. Sherrington R, Rogaev E, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero Y, Pinessi L, Nee L, Chumakov Y, Pollen D, Brookes A, Sanseau P, Polinsky J, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH. 1995. Cloning a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
31. Taddei K, Kwok JB, Kril JJ, Halliday GM, Creasey H, Hallupp M, Fisher C, Brooks WS, Chung C, Andrews C, Masters CL, Schofield PR, Martins RN. 1998. Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease. Neuroreport 9:3335-3339.
32. Takami K, Terai K, Matsuo A, Walker DG, McGeer PL. 1997. Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains. Brain Res 748:122-130.
33. Tanahashi H, Kawakatsu S, Kaneko M, Yamanaka H, Takahashi K, Tabira T. 1996. Sequence analysis of presenilin-1 gene mutations in Japanese Alzheimer's disease patients. Neurosci Lett 218:139-141.
34. Tysoe C, Whittaker J, Xuereb J, Cairns NJ, Cruts M, Van Broeckhoven C, Wilcock G, Rubinsztein DC. 1998. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet 62:70-76.
35. Wisniewski T, Dowjat WK, Buxbaum JD, Khorkova O, Efthimiopoulos S, Kulczycki J, Lojkowska W, Wegiel J, Wisniewski HM, Frangione B. 1998. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 23 years. Neuroreport 9:217-221.